Primary Image

Arm cycling

Clinical Trial

Arm and Leg Cycling for Accelerated Recovery from SCI

IRB Protocol Number STU00216731

Contact

Grace Hoo ghoo@sralab.org

Objective

The Shirley Ryan AbilityLab is seeking participants with incomplete spinal cord injury (SCI) to study the effects of combined arm and leg cycling on an individual’s walking ability.

During the study, participants will complete 5 training sessions (~1.5hrs per session) per week with cycling for 12 consecutive weeks.

Additionally, we will complete several assessments at baseline, at 3-week intervals during the training period, after the training period, and 6 months after the training period. The assessments include tests for sense, strength, balance, stability, spasticity/stiffness, walking speed, walking distance, muscle strength, gait analysis, muscle responses due to transcranial magnetic stimulation (TMS) of your brain, and brain-muscle connectivity via electro-encephalography (EEG). The assessments (~7hrs per timepoint) may be split across several days.

Who Can Participate

  • Incomplete spinal cord injury at T11 or above, at least 1 year ago
  • Incomplete paraplegia or tetraplegia
  • Injury occurred at least 1 year ago
  • Able to walk independently for at least 10 meters (30 feet)
  • Walking speed is slower than 2.62ft per second
  • Able to arm cycle for at least 15 min
  • English speaking adults, 18-75 years

Compensation

Participants will be compensated up to $900 for their time and effort in completing all study visits including the 6-month follow-up visit. Parking in the Shirley Ryan AbilityLab garage will be covered with vouchers.

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan AbilityLab. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all